Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,021.70 -3.58 (-0.35%)
Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy? ↗
Pfizer's weight management pipeline just got a boost. 
Via The Motley Fool
News headline image
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗
AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation. 
Via Benzinga
Topics ETFs
News headline image
Consumer Brands Shake Things Up...With Mergers ↗
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting... 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation
As November 2025 unfolds, the global financial markets find themselves at a critical juncture, characterized by a palpable sense of unease over elevated valuations in specific sectors and a pronounced... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Nvidia and 19 Other Stocks Now Make Up 50% of the S&P 500. Here's What It Means for Your Investment Portfolio. ↗
Buying the S&P 500 takes the belief that today's leading companies deserve their lofty valuations. 
Via The Motley Fool
Topics Stocks
News headline image
How Novo Nordisk Just Undercut Eli Lilly And The Trump Administration ↗
Novo Nordisk undercut Eli Lilly and the Trump administration on Monday, slashing the cash price of its Wegovy and Ozempic. 
Via Investor's Business Daily
Topics Government
News headline image
White House Economic Advisor Kevin Hassett Says India Trade Deal Talks Got ‘Pretty Complicated’, But Remains Hopeful: Report ↗
In an interview with CNBC, Hassett remained optimistic about striking an agreement with India, but added that there are a lot of different variables in the India-U.S. relationship. 
Via Stocktwits
News headline image
Novo Nordisk Offers WeGovy, Ozempic For $199 A Month As It Takes On Eli Lilly’s Zepbound ↗
The Danish drugmaker has announced that this offer is applicable to cash-paying patients looking to purchase introductory doses of Wegovy and Ozempic. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗
Healthcare stocks have far outperformed the broader market over the past month. 
Via The Motley Fool
Topics ETFs Government World Trade
News headline image
2 Mooning Stocks to Keep an Eye On and 1 We Ignore
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant... 
Via StockStory
News headline image
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? ↗
Investors will be watching what Trump makes happen. 
Via The Motley Fool
Topics Government
News headline image
Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock ↗
Drugs for weight loss and diabetes are taking Eli Lilly to new heights. 
Via The Motley Fool
News headline image
Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗
Ten large-cap standouts—including Maplebear, Tower Semiconductor, Eli Lilly, On Holding, Albemarle, and key gold/silver miners—rallied last week on strong earnings, upbeat guidance, analyst upgrades,... 
Via Benzinga
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize. 
Via Benzinga
Topics ETFs
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation. 
Via Benzinga
News headline image
Government Reopens, AI Stocks Slide On Supply Crunch Fears: This Week In Markets ↗
Markets digest U.S. government reopening, hawkish Fed outlook, and AI sell-off as CoreWeave crashes 25%. 
Via Benzinga
Topics Artificial Intelligence Economy
News headline image
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Novo Nordisk Brings Back Former CEO To Lead Board ↗
Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday. 
Via Stocktwits
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗
Via MarketBeat
News headline image
Ozempic Maker Novo Nordisk Faces Board Shakeup ↗
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market. 
Via Benzinga
News headline image
Why Is Everyone Talking About Novo Nordisk Stock? ↗
There is hardly a dull moment for the drugmaker these days. 
Via The Motley Fool
News headline image
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗
The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction. 
Via Stocktwits
News headline image
Immuneering (IMRX) Q3 2025 Earnings Transcript ↗
Immuneering (IMRX) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens
The United States government has recently emerged from its longest shutdown in history, a 43-day impasse that concluded on November 12, 2025. This protracted closure plunged the nation into an... 
Via MarketMinute
Topics Credit Cards Economy World Trade
News headline image
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs ↗
The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines. 
Via Stocktwits
News headline image
Here Are the Top Growth Healthcare Stocks Every New Investor Should Know ↗
These top growth stocks have plenty of room left to run. 
Via The Motley Fool
News headline image
2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors ↗
Healthcare stocks have plenty to offer new investors. 
Via The Motley Fool
1 Incredible Reason to Buy LLY's Stock in November ↗
Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher. 
Via The Motley Fool
Topics Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.